Wednesday - April 9, 2025
Ropes & Gray Advises FibroGen in $160 Million Sale of Fibrogen China to AstraZeneca
March 06, 2025
BOSTON, Massachusetts, March 6 [Category: BizLaw/Legal] -- Ropes and Gray, a law firm, issued the following news:

* * *

Ropes & Gray Advises FibroGen in $160 Million Sale of Fibrogen China to AstraZeneca

Ropes & Gray represented FibroGen in the sale of its China subsidiary, Fibrogen China, to AstraZeneca for approximately $160 million. The transaction was announced in a Feb. 20 press release.

FibroGen, Inc. is a biopharmaceutical compa . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products